A Case for Reframing ‘Skin of Color’ - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Case for Reframing ‘Skin of Color’

The term that transformed dermatology is now blurring the very distinctions it was meant to sharpen.

  • By

  • Kerri Miller

  • March 20, 2026

  • 2 min

Share

Objective:

To examine the evolution and implications of the term 'skin of color' (SOC) in dermatology and propose a more precise framework for its use.

Approach:
    Key Findings:
    • The Fitzpatrick scale inadequately represents darker skin types.
    • SOC is often used as a catch-all term that can obscure clinically meaningful differences.
    • A more granular approach is needed to enhance individualized care in dermatology.
    Interpretation:

    While SOC has advanced equity in dermatology, its broad application can lead to imprecision in clinical settings, necessitating a more detailed understanding of its components.

    Limitations:
    • The proposed tools for measuring SOC components are underused due to integration challenges.
    • Refining the term SOC may create tension regarding its visibility and importance in dermatology.
    Conclusion:

    The authors advocate for a nuanced application of SOC in clinical and research contexts to improve patient care and outcomes.

    Sources:

Original Source(s)

A Case for Reframing ‘Skin of Color’

  • by Kerri Miller

  • March 20, 2026

Related Content

FDA's New Pulse Oximeter Guidance: Stricter Standards, Ongoing Challenges

The FDA's 2025 pulse oximetry guidance introduces stricter accuracy standards, larger study cohorts, and objective skin pigmentation assessment to address measurement bias in darker-skinned patients.

Side Effects: The Details Hiding in Plain Sight

Phones in class, a 25-year prescription gone wrong, pickleball's hidden danger, and why your spin class is too loud — four findings hiding in everyday care.

Low Vitamin D Persists Year-Round in Northern Britain

Screening data from a UK clinical trial found low vitamin D levels in 55% of older patients and 72% of ethnic patients, with little variation despite summer months.